The chemoprotective hormetic effects of rosmarinic acid

Edward J Calabrese1, Peter Pressman2, A Wallace Hayes3

  • 1School of Public Health and Health Sciences, Department of Environmental Health Sciences, Morrill I-N344, University of Massachusetts, Amherst, MA, 01003, United States of America.

PubMed

Insights

Rosmarinic acid exhibits widespread hormetic dose responses across various biological models. This study assesses these responses, their mechanisms, and implications for health and disease prevention.

Area of Science:

  • Pharmacology and Toxicology
  • Nutritional Science
  • Biochemistry

Background:

  • Rosmarinic acid, a plant-derived polyphenol, is investigated for its chemopreventive potential.
  • It is widely consumed and studied for therapeutic applications.
  • Existing research highlights its complex, multi-system biological effects.

Purpose of the Study:

  • To provide the first comprehensive assessment of rosmarinic acid-induced hormetic dose responses.
  • To analyze the quantitative features and mechanistic underpinnings of these responses.
  • To evaluate the biomedical, clinical, and public health implications of rosmarinic acid's hormetic effects.

Main Methods:

  • Literature review and synthesis of existing cellular, whole animal, and molecular studies.
  • Analysis of dose-response data across diverse biological models and endpoints.
  • Evaluation of mechanistic foundations and extrapolation of findings.

Main Results:

  • Rosmarinic acid demonstrates widespread hormetic dose responses in numerous biological models and cell types.
  • These responses are observed across a broad range of physiological and pathological endpoints.
  • Quantitative features and mechanistic bases of these hormetic effects are identified.

Conclusions:

  • Rosmarinic acid's hormetic effects are a significant characteristic influencing its biological activity.
  • Understanding these dose-response relationships is crucial for optimizing therapeutic and chemopreventive applications.
  • Further research is warranted to fully elucidate the clinical and public health relevance of rosmarinic acid's hormetic properties.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394